Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Net Income (2016 - 2025)

Historic Net Income for Bio-Techne (TECH) over the last 17 years, with Q4 2025 value amounting to $38.0 million.

  • Bio-Techne's Net Income rose 893.95% to $38.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $30.0 million, marking a year-over-year decrease of 7461.18%. This contributed to the annual value of $22.2 million for FY2025, which is 8261.11% down from last year.
  • Latest data reveals that Bio-Techne reported Net Income of $38.0 million as of Q4 2025, which was up 893.95% from $38.2 million recorded in Q3 2025.
  • In the past 5 years, Bio-Techne's Net Income registered a high of $89.7 million during Q3 2022, and its lowest value of -$68.8 million during Q2 2025.
  • Moreover, its 5-year median value for Net Income was $45.5 million (2021), whereas its average is $38.9 million.
  • As far as peak fluctuations go, Bio-Techne's Net Income soared by 56312.36% in 2022, and later crashed by 1621943.79% in 2025.
  • Quarter analysis of 5 years shows Bio-Techne's Net Income stood at $72.1 million in 2021, then plummeted by 30.61% to $50.0 million in 2022, then plummeted by 45.08% to $27.5 million in 2023, then increased by 27.03% to $34.9 million in 2024, then rose by 8.94% to $38.0 million in 2025.
  • Its Net Income was $38.0 million in Q4 2025, compared to $38.2 million in Q3 2025 and -$68.8 million in Q2 2025.